Multiple sclerosis (MS) is one of the most common autoimmune diseases affecting the brain and spinal cord, with 2.9 million ...
The damage can lead to both sudden “flares” of inflammation and a slow worsening of symptoms over time. Historically, MS has been broken down into specific subtypes, as detailed below. But the reality ...
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a rare autoimmune condition in which the body's ...
Everyday Health on MSN
The Effect of Menopause on Multiple Sclerosis
Aging and shifting hormone levels influence how MS changes over time, and the overlap of these factors during midlife can ...
Dean was diagnosed with multiple sclerosis (MS) in 2005. “Multiple sclerosis is a disease that causes breakdown of the ...
The first (FENhance 2) of two pivotal RMS studies met its primary endpoint, showing investigational fenebrutinib ...
Request To Download Free Sample of This Strategic Report @ The symptoms of multiple sclerosis differ widely, subject to the extent of damage and the number of neurons affected. Some of the symptoms ...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the first Phase III (FENhance 2) of ...
When your body’s immune cells attack you instead of protecting you, today’s treatments tamp down the friendly fire but they ...
For years scientists have suspected that the Epstein-Barr virus (EBV)—a type of herpesvirus that infects 94 percent of the ...
Roche’s fenebrutinib shows unprecedented positive phase III results as the potential first and only BTK inhibitor in both relapsing and primary progressive multiple sclerosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback